Geode Capital Management, LLC Rani Therapeutics Holdings, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 172,261 shares of RANI stock, worth $251,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172,261
Previous 150,734
14.28%
Holding current value
$251,501
Previous $572,000
34.97%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.76 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.04 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$720,6321.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$654,7980.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$442,0040.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $35.8M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...